11 February 2014 - Deborah Wilkes
Archived
Probi's board has rejected a takeover offer from Germany's Symrise, which values the Swedish probiotics specialist at around SEK375 million (US$58 million).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.